Almost 140,000 people die with a drug-resistant bacterial infection in Brazil every year due in large part to shortcomings in access, stewardship, and innovation for antimicrobials. Brazil’s existing Productive Development Partnerships system could be modified to reduce incentives for overselling an...
Antimicrobial resistance (AMR) poses a threat to global health security worldwide, and India carries one of the largest burdens of drug-resistant pathogens. The widespread misuse and overuse of antimicrobials is a major cause of the emergence and spread of resistant microorganisms. This study assess...
Countries moving towards universal health coverage are challenged about what new health benefits and interventions they will add to their national health programs. We propose a new framework organized in three layers that outlines the features or characteristics to consider when designing and buildi...
Rigorous, explicit, evidence-informed priority-setting (EIPS) in healthcare is an essential instrument for achieving value for money. Growing pressures on healthcare budgets, combined with the post-COVID-19 fiscal crises and plateauing development assistance for health, make institutionalising EIPS ...
HTAIn has shown a good realised return on investment of 9:1. To further increase the return on investment, India can strategically scale up HTAIn and carry out careful selection of which topics to carry out HTAs on.
The policy discussions about PPR are noteworthy. But the global public sector is underinvesting in pandemic response. This creates the illusion of safety without the finance or planning in place to provide it. We cannot delay planning for response financing when the next pandemic hits, by which time...
Health aid has helped domestic financing achieve historic gains in global health but there is much still to be done. Six major issues prevent aid from being more effective, fit for the future, and aligned with country priorities: funding volatility, aid fragmentation, the displacement of domestic fi...